×

Uh-oh, it looks like your Internet Explorer is out of date.

For a better shopping experience, please upgrade now.

Hormone Therapy in Breast and Prostate Cancer / Edition 1
     

Hormone Therapy in Breast and Prostate Cancer / Edition 1

by JORDAN V. CRAIG
 

See All Formats & Editions

ISBN-10: 0896036731

ISBN-13: 9780896036734

Pub. Date: 01/02/2002

Publisher: Springer-Verlag New York, LLC

Researchers and clinicians describe the principles underlying the use of hormone antagonists for the treatment of endocrine-dependent cancers. They assess the actions of new and established agents and illustrate new applications of hormonal chemoprevention for breast cancer. The contributors, representing both academia and industry in the US, Europe, Australia, and

Overview

Researchers and clinicians describe the principles underlying the use of hormone antagonists for the treatment of endocrine-dependent cancers. They assess the actions of new and established agents and illustrate new applications of hormonal chemoprevention for breast cancer. The contributors, representing both academia and industry in the US, Europe, Australia, and Japan, cover history, laboratory discovery, and clinical practice. Of interest to medical and surgical oncologists, urologists, cancer researchers, physicians, and pharmacologists. Annotation c. Book News, Inc., Portland, OR (booknews.com)

Product Details

ISBN-13:
9780896036734
Publisher:
Springer-Verlag New York, LLC
Publication date:
01/02/2002
Series:
Cancer Drug Discovery and Development Series
Edition description:
2002
Pages:
420
Product dimensions:
5.98(w) x 9.02(h) x 0.04(d)

Table of Contents

An Introduction to the Regulation of Sex Steroids for the Treatment of Cancer
V. Craig Jordan and Barrington J. A. Furr

Part I. Preclinical Antiestrogens

Antiestrogens and the Cell Cycle
Colin K. W. Watts, Owen W. J. Prall, Jason S. Carroll, Nicholas R. C. Wilcken, Eileen M. Rogan, Elizabeth A. Musgrove, and Robert L. Sutherland

Drug Resistance to Antiestrogens
Ruth M. O'Regan, Anait S. Levenson, Gale M. England, Kathy A. Yao, Henry D. Muenzner, Hiroyuki Takei, and V. Craig Jordan

Mechanisms of Liver Carcinogenesis by Antiestrogens
David H. Phillips

The Effects of Triphenylethylene Antiestrogens on Parameters of Multistage Hepaarcinogenesis in the Rat
Yvonne P. Dragan and Henry C. Pitot

Preclinical Studies of Raloxifene and Related Compounds
Robin Fuchs-Young. Pure Antiestrogens, Alan E. Wakeling

Part II. Antiestrogens: Clinical

Tamoxifen for the Treatment of Breast Cancer
V. Craig Jordan

Clinical Utility of New Antiestrogens
Ruth M. O'Regan and William J. Gradishar

Breast Cancer Prevention with Antiestrogens
Monica Morrow and V. Craig Jordan

Part III. Inhibition of Estrogen Synthesis

Aromatase Inhibitors
Paul E. Goss and Caroline C. Reid

Clinical Utility of Aromatase Inhibitors
K. Shenton, Mitchell Dowsett, and Michael Dukes

LH-RH Agonists for the Treatment of Breast Cancer: Development and Current Status
Roger W. Blamey

Part IV. Androgen and Androgen Withdrawal

Molecular Action of Androgens
Shutsung Liao, Junichi Fukuchi, and Yung-Hsi Kao

Steroidal Antiandrogens
Fritz H. Schröder and Albert Radlmaier

Nonsteroidal Antiandrogens
Geert J. C. M. Kolvenbag and Barrington J. A. Furr

LH-RH Agonist Role in Prostate Cancer Management
Amir V. Kaisary

Part V. Perspective on Progress

Recent Progress in Breast Cancer Research
V. Craig Jordan and Barrington J. A. Furr

Customer Reviews

Average Review:

Post to your social network

     

Most Helpful Customer Reviews

See all customer reviews